Cargando…
Repurposing simvastatin as a therapy for preterm labor: evidence from preclinical models
Preterm birth (PTB), the leading cause of neonatal morbidity and mortality, urgently requires novel therapeutic agents. Spontaneous PTB, resulting from preterm labor, is commonly caused by intrauterine infection/inflammation. Statins are well-established, cholesterol-lowering drugs that can reduce i...
Autores principales: | Boyle, Ashley K., Rinaldi, Sara F., Rossi, Adriano G., Saunders, Philippa T. K., Norman, Jane E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Federation of American Societies for Experimental Biology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338657/ https://www.ncbi.nlm.nih.gov/pubmed/30312114 http://dx.doi.org/10.1096/fj.201801104R |
Ejemplares similares
-
Decidual Neutrophil Infiltration Is Not Required for Preterm Birth in a Mouse Model of Infection-Induced Preterm Labor
por: Rinaldi, Sara F., et al.
Publicado: (2014) -
Interventions for Infection and Inflammation-Induced Preterm Birth: a Preclinical Systematic Review
por: Miller, Faith A., et al.
Publicado: (2022) -
Maternal serum cytokines in the prediction of preterm labor and response to tocolytic therapy in preterm labor women
por: Shahshahan, Zahra, et al.
Publicado: (2014) -
Immune cells and preterm labour: do invariant NKT cells hold the key?
por: Rinaldi, S.F., et al.
Publicado: (2015) -
The use of maternal C-reactive protein in the predicting of preterm labor and tocolytic therapy in preterm labor women
por: Shahshahan, Zahra, et al.
Publicado: (2014)